FDA Inspection
NEOLPHARMA, INC.NEOLPHARMA, INC. – FDA Inspection, Mar 10, 2026
Record Details
This FDA Inspection record concerns NEOLPHARMA, INC., with an inspection on March 10, 2026, issued by the San Juan District Office, covering human drugs.
View Company Profile
ID · 0f95eddc-787e-4d59-aecb-be0b8a4ebb5a
Inspection Facts
- Inspection number
- 1304150
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.56(a)Sanitation--buildings not clean, free of infestation
Full citation text and observation details available on the Dashboard.
Other FDA inspections of NEOLPHARMA, INC.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| April 1, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 5, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 7, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 18, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 7, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for NEOLPHARMA, INC.
- FDA Inspection 1166181 - 2022-04-01
- FDA Inspection 1078192 - 2019-02-05
- FDA Inspection 1018694 - 2017-06-07
- FDA Inspection 929761 - 2015-06-18
- FDA Inspection 822275 - 2013-03-07
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.